CClinicalTrials.gg
RecruitingNCT06574724Updated Dec 5, 2024

Transfer of Microorganisms Between Green Areas and Humans

An interventional study of Visiting a green space in Microbial Colonization, sponsored by Universiteit Antwerpen. Recruiting at 1 site in Belgium. Open to participants aged 4 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Universiteit Antwerpen · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
4 Years and older
Sex
All
01

Study summary

The goal of this study is to understand how visiting green areas affects the human microbiome through microbial transfer. Additionally, the project aims to understand which environmental, health and lifestyle factors can influence these microbiome changes. Participants will visit a green area, provide microbiome samples before and after the visit, and complete questionnaires related to environmental, health, lifestyle and demographic factors.

Read the detailed description

Several hypotheses propose that the modern surge in immune disorders is related to diminished contact with nature. Specifically, the Biodiversity hypothesis emphasizes that contact with natural environments enriches the human microbiome and is necessary for promoting immune balance. This project aims to investigate whether visiting green areas can contribute to changes in human microbiome composition. Additionally, the investigators aim to explore the environmental, health and lifestyle factors that can influence these microbiome changes. Adults and/or children will be asked to visit a green space (such as an urban park) and perform specific activities (such as walking or pushing a stroller) for a defined time period. Before and after this visit, swabs of their skin and nose will be collected to analyze microbiome changes. In addition, questionnaires will be administered to the participants, with the goal to align microbiome changes with environmental, health, lifestyle and demographic factors.

02

Conditions studied

  • Microbial Colonization

Keywords

  • green areas
  • nature
  • microbiome
  • biodiversity
  • sequencing
03

In context

Communicable Diseases

4,451 studies on the registry are indexed under Communicable Diseases; 521 are open to participants now.

This study's planned enrollment of 150 is above the median of 121 across 2,717 interventional studies indexed under Communicable Diseases.

Browse Communicable Diseases studies →

Lead sponsor

Universiteit Antwerpen is the lead sponsor of 128 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria:

Children (min. 4 years old) and adult participants (18+) of any gender in generally good health.

No strict exclusion criteria will be set in advance.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Green space intervention

    Participants that visit a green space

    Other: Visiting a green space

Interventions

  • OtherVisiting a green space

    Participants are asked to visit a green space for a defined time period

06

What researchers measure

Primary outcomes

  1. Microbiome changes

    Microbiome sequencing will be performed to assess changes in microbial community composition of nasal and skin swabs, focusing on abundances and diversity of different microorganisms and their genes

    Time frame: Two time points directly before and after the intervention (on 1 day)

Secondary outcomes

  1. Specific microorganisms within the skin and nasal microbiomes

    Specific microorganisms within the participants' microbiomes will be assessed through culturing of swabs and/or quantification via qPCR

    Time frame: Two time points directly before and after the intervention (on 1 day)

  2. Associations between the human microbiome and environment

    Human microbiome composition and diversity (as assessed in outcome "Microbiome changes") will be correlated with the green space environment characteristics, such as the environmental (microbiome) biodiversity

    Time frame: Two time points directly before and after the intervention (on 1 day)

Other outcomes

  1. Self-reported lifestyle

    Lifestyle will be assessed using a short questionnaire to understand how it might impact the microbiome (as assessed in outcome "Microbiome changes"), reflecting lifestyle-related parameters such as weekly time spent outdoors (in hours) and frequency of exposure to green environments (e.g., once a year)

    Time frame: One time point directly before or after the intervention (on 1 day)

  2. Self-reported health

    Self-reported general health will be assessed using a short questionnaire to understand how it might impact the microbiome (as assessed in outcome "Microbiome changes"), reflecting health-related parameters such as a health rating (from very poor to very good)

    Time frame: One time point directly before or after the intervention (on 1 day)

  3. Self-reported demographic information

    Demographic information will be assessed using a short questionnaire to understand how it might impact the microbiome (as assessed in outcome "Microbiome changes"), reflecting demographic parameters such as age (in years), gender, and parent-child relationship (having one or more children)

    Time frame: One time point directly before or after the intervention (on 1 day)

07

Study locations

1 of 1 sites recruiting
  • Universiteit Antwerpen
    Antwerp, 2020, Belgium
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06574724
Lead sponsor
Universiteit Antwerpen
Responsible party
Irina Spacova (Prof., Universiteit Antwerpen) — Principal investigator
First posted
Aug 28, 2024
Start date
Aug 27, 2024
Primary completion
Jul 7, 2027 (estimated)
Completion
Jul 7, 2027 (estimated)
Last update
Dec 5, 2024

Study contacts

Irina Spacova, Prof.
Contact
irina.spacova@uantwerpen.be
+32 3 265 32 89
Irina Spacova, Prof.
principal investigator · Universiteit Antwerpen
Stijn Verhulst, Prof. dr.
principal investigator · Universiteit Antwerpen and University Hospital Antwerp (UZA)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion